Dr. David Lawson

About Dr. David Lawson

Dr. David Lawson offers specialized care in many areas. These include oncology, inflammatory diseases, diabetes, neurology and advanced cardiac screenings. His practice uses many diagnostic and treatment services. These include lab tests, imaging, advanced screenings and procedures. Dr. Lawson also provides care for ongoing conditions, such as mesothelioma.

He possesses expertise in clinical trials research, serving as a principal investigator and scientific liaison with experience in public health, biomedical statistics and publication editing. Dr. Lawson often collaborates with fellow physicians, physician assistants, researchers and scientific leaders to ensure accurate, evidence-based medical content. 

His practice uses AI technology to help ensure complex medical information is easy to understand. Dr. Lawson and his practice are also responsible for the safety of subjects involved in clinical trials and for executing studies under strict U.S. Food and Drug Administration regulations. 

Dr. Lawson’s Role as Expert Contributor on Asbestos.com

The experience in primary care, clinical trials, medical writing, reviewing and editing that he brings to his role as a contributor are vital. He shares his knowledge, experience and professional take on issues important to patients and their loved ones.

Specialties of Dr. David Lawson 

• Cardiology
• Comprehensive Disease management
• Gastroenterology
• Inflammatory diseases
• Medical review 
• Neurology 
• Oncology
• Primary and Family medicine

Dr. David Lawson’s Experience and Medical Education

• LFM Medical, Family Medicine Physician
• Research Solutions, Medical Writer and Reviewer 
• Southern Illinois University School of Medicine (Residency)
• Deaconess Hospital, St. Louis University School of Medicine (Transitional Internship)
• University of California, Los Angeles (M.D.)
• University of California, Los Angeles (B.S.)

Publications of Dr. David Lawson 

Lawson, D. et al. (2023, March 15). Early Detection and Prognostic Assessment of Cutaneous Melanoma Consensus on Optimal Practice and the Role of Gene Expression Profile Testing. Jama Network. 

Lawson, D. et al. (2021, June 23). Acquired Resistance to KRASG12C Inhibition in Cancer. The New England Journal of Medicine. 

Lawson, D. et al. (2020, November 2). A longitudinal examination of the frequency and correlates of self-reported neurobehavioural disability following stroke. Taylor & Francis Online.

Lawson, D. et al. (2013, August 27). The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma. Nature Reviews Clinical Oncology.

Lawson, D. et al. (2012, May 27). Structural and functional dissection of aminocoumarin antibiotic biosynthesis: a review. Springer Nature Link